{"nct_id":"NCT03888534","title":"Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)","status":"WITHDRAWN","status_verified_date":"2020-09","start_date":"2020-10-31","start_date_type":"ESTIMATED","primary_completion_date":"2022-08-30","primary_completion_date_type":"ESTIMATED","completion_date":"2022-08-30","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["TAK"]}